pipobroman has been researched along with Benign Neoplasms in 6 studies
Pipobroman: An antineoplastic agent that acts by alkylation.
pipobroman : An N-acylpiperazine that is piperazine in which each of the nitrogens has been acylated by a 3-bromopropionoyl group. An anti-cancer drug.
| Excerpt | Relevance | Reference |
|---|---|---|
| "From 1968 to 1993, 179 newly diagnosed patients with polycythemia vera (PV) were enrolled in a prospective study using pipobroman as first chemotherapy." | 9.10 | Long-term outcomes of polycythemia vera patients treated with pipobroman as initial therapy. ( Bernard, JF; Bruno, F; Gardin, C; Kiladjian, JJ; Renoux, M, 2003) |
| "Acute myeloid leukaemia, myelofibrosis and solid tumours occurred in three, two and seven patients with a 10-year cumulative risk of 3%, 2% and 7% respectively." | 5.31 | Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis. ( Astori, C; Baratè, C; Bernasconi, P; Brusamolino, E; Canevari, A; Cazzola, M; Corso, A; Lazzarino, M; Malabarba, L; Orlandi, E; Pascutto, C; Passamonti, F, 2002) |
| "From 1968 to 1993, 179 newly diagnosed patients with polycythemia vera (PV) were enrolled in a prospective study using pipobroman as first chemotherapy." | 5.10 | Long-term outcomes of polycythemia vera patients treated with pipobroman as initial therapy. ( Bernard, JF; Bruno, F; Gardin, C; Kiladjian, JJ; Renoux, M, 2003) |
| "Acute myeloid leukaemia, myelofibrosis and solid tumours occurred in three, two and seven patients with a 10-year cumulative risk of 3%, 2% and 7% respectively." | 1.31 | Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis. ( Astori, C; Baratè, C; Bernasconi, P; Brusamolino, E; Canevari, A; Cazzola, M; Corso, A; Lazzarino, M; Malabarba, L; Orlandi, E; Pascutto, C; Passamonti, F, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, R | 1 |
| Elf, S | 1 |
| Shan, C | 1 |
| Kang, HB | 1 |
| Ji, Q | 1 |
| Zhou, L | 1 |
| Hitosugi, T | 1 |
| Zhang, L | 1 |
| Zhang, S | 1 |
| Seo, JH | 1 |
| Xie, J | 1 |
| Tucker, M | 1 |
| Gu, TL | 1 |
| Sudderth, J | 1 |
| Jiang, L | 1 |
| Mitsche, M | 1 |
| DeBerardinis, RJ | 1 |
| Wu, S | 1 |
| Li, Y | 1 |
| Mao, H | 1 |
| Chen, PR | 1 |
| Wang, D | 1 |
| Chen, GZ | 1 |
| Hurwitz, SJ | 1 |
| Lonial, S | 1 |
| Arellano, ML | 1 |
| Khoury, HJ | 1 |
| Khuri, FR | 1 |
| Lee, BH | 1 |
| Lei, Q | 1 |
| Brat, DJ | 1 |
| Ye, K | 1 |
| Boggon, TJ | 1 |
| He, C | 1 |
| Kang, S | 1 |
| Fan, J | 1 |
| Chen, J | 1 |
| Kiladjian, JJ | 1 |
| Gardin, C | 1 |
| Renoux, M | 1 |
| Bruno, F | 1 |
| Bernard, JF | 1 |
| Passamonti, F | 1 |
| Malabarba, L | 1 |
| Orlandi, E | 1 |
| Pascutto, C | 1 |
| Brusamolino, E | 1 |
| Astori, C | 1 |
| Baratè, C | 1 |
| Canevari, A | 1 |
| Corso, A | 1 |
| Bernasconi, P | 1 |
| Cazzola, M | 1 |
| Lazzarino, M | 1 |
| Greenwald, ES | 1 |
| Seidenglanz, G | 1 |
| Hermanský, F | 1 |
3 reviews available for pipobroman and Benign Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; | 2015 |
Cancer chemotherapy. II.
Topics: Animals; Antineoplastic Agents; Asparaginase; Azathioprine; Bleomycin; Cytarabine; Dactinomycin; Dau | 1972 |
[Chemotherapy of malignant tumors. 44].
Topics: Adrenal Cortex Hormones; Alkylating Agents; Androgens; Antibiotics, Antineoplastic; Antimetabolites; | 1970 |
1 trial available for pipobroman and Benign Neoplasms
| Article | Year |
|---|---|
Long-term outcomes of polycythemia vera patients treated with pipobroman as initial therapy.
Topics: Actuarial Analysis; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Cause of Deat | 2003 |
2 other studies available for pipobroman and Benign Neoplasms
| Article | Year |
|---|---|
Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis.
Topics: Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Humans; Leukemia, Myeloid; Male; Middle A | 2002 |
[Clinical evaluation of antineoplastic agents].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Cytarabine; Humans; Neoplasms; Nitrosourea Compo | 1972 |